Dr. Anand Srinivasan

Vice President of Technology and Innovations, and Head of the Center for Innovations and Biodesign at BioBridge Global

Speaker

Dr. Anand Srinivasan is the Vice President of Technology and Innovations at BioBridge Global, San Antonio, Texas. He began his career with a baccalaureate degree in Biotechnology from Anna University at Chennai, India. He earned his M.S. and Ph.D. in Biomedical Engineering from The University of Texas at San Antonio. Prior to his appointment at BioBridge Global, he served as a principal investigator at the coagulation and blood research program of the U.S. Army Institute of Surgical Research. He has published several peer-reviewed research articles and has been awarded with many patents. In the regenerative medicine space, his work has led to the development of osteobiologics, xeno-free supplement formulation, and novel potency assays for cellular therapies. At BioBridge Global, he leads a team of engineers and scientists working on the expansion of mammalian and microbial cells using bioreactors, development of miniaturized technologies for assay and therapeutics development, media formulations, lab-on-a-chip microfluidics, and high-throughput robotics-assisted platforms. He enables front‐end customer development to facilitate the creation of new product, assays and/or service opportunities for BioBridge Global and its subsidiaries. He is also responsible for applications development, inventing prototypes, potency assays, and deriving process-related solutions. He champions the applications of artificial intelligence (AI), Industry 4.0, predictive analytics, and machine learning (ML) pertinent to BBG and subsidiaries. He also examines the implications of technology trends such as blockchain, digitalization, big data, deep learning, and other state-of-the-art technologies in the field of advanced therapies. Dr. Srinivasan is an active member of the International Society for Cell and Gene Therapy (ISCT), where he serves as a working member for the process development and manufacturing committee, and the process automation, analytics and development sub-committee. He has an advisory role with Vitrafy Life Sciences, and he serves as the Chair on the advisory board of the department of biomedical engineering at the University of Texas at San Antonio.